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Introduction
Mortality prediction systems have been advocated as means
of evaluating the performance of intensive care units (ICUs)
[1]. These systems allow adjustment to the severity of illness
of the patient population. Acute Physiology and Chronic
Health Evaluation (APACHE) II and Simplified Acute Physiol-
ogy Score (SAPS) II measure severity of illness by a numeric
score [2,3] based on physiologic variables selected because
of their impact on mortality: the sicker the patient, the more
deranged the values and the higher the score. The numeric
scores are then converted into predicted mortality by using a
logistic regression formula developed and validated on popu-
APACHE = Acute Physiology and Chronic Health Evaluation; CI = confidence interval; DNR = ‘do not resuscitate’; GCS = Glasgow Coma Score;
ICU = intensive care unit; LOS = length of stay; MPM = Mortality Probability Model; ROC = receiver operating characteristic; SAPS = Simplified
Acute Physiology Score; SMR = standardized mortality ratio.
Abstract
Introduction The purpose of this study is to assess the performance of Acute Physiology and Chronic
Health Evaluation (APACHE) II, Simplified Acute Physiology Score (SAPS) II, Mortality Probability
Model MPM II0 and MPM II24 systems in a major tertiary care hospital in Riyadh, Saudi Arabia.
Methods The following data were collected prospectively on all consecutive patients admitted to the
Intensive Care Unit between 1 March 1999 and 31 December 2000: demographics, APACHE II and
SAPS II scores, MPM variables, ICU and hospital outcome. Predicted mortality was calculated using
original regression formulas. Standardized mortality ratio (SMR) was computed with 95% confidence
intervals (CI). Calibration was assessed by calculating Lemeshow-Hosmer goodness-of-fit C statistics.
Discrimination was evaluated by calculating the Area Under the Receiver Operating Characteristic
Curves (ROC AUC).
Results Predicted mortality by all systems was not significantly different from actual mortality [SMR for
MPM II0: 1.00 (0.91–1.10), APACHE II: 1.00 (0.8–1.11), SAPS II: 1.09 (0.97–1.21), MPM II24 0.92
(0.82–1.03)]. Calibration was best for MPM II24 (C-statistic: 14.71, P = 0.06). Discrimination was best
for MPM II0 (ROC AUC:0.85) followed by MPM II24 (0.84), APACHE II (0.83) then SAPS II (0.79).
Conclusions In our ICU population: 1) Overall mortality prediction, estimated by standardized mortality
ratio, was accurate, especially for MPM II0 and APACHE II. 2) MPM II24 has the best calibration. 3)
SAPS II has the lowest calibration and discrimination. The local performance of MPM II24 in addition to
its ease-to-use makes it an attractive model for mortality prediction in Saudi Arabia.
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lations of ICU patients. Mortality Probability Models (MPM) II
differ slightly in that they use categorical variables (with the
exception of age) for mortality prediction [4].
Before the clinical application of any of these systems, they
must be validated on the population under evaluation [5,6].
These systems have been assessed for validity in several
countries [7–9]. We report here the result of our validation
study of the four systems in ICU population in a tertiary care
center in Saudi Arabia.
Methods
King Fahad National Guard Hospital is a 550-bed tertiary
care center in Riyadh, Saudi Arabia. The 12-bed medical–sur-
gical ICU has 600 admissions a year. The hospital also has a
coronary care unit and a cardiac surgical intensive care unit.
Patients admitted to these units were not included in the
study. The unit is run by full-time intensivists and has 24-hour
immediate access to other medical and surgical specialties.
Our nurse-to-patient ratio is approximately 1:1.2. This high
ratio has been maintained because of the high acuity of care.
Our ICU database was established in March 1999 to record
ICU admissions. The present study presents information on
all consecutive admissions between 1 March 1999 and 31
December 2000. Data were collected by one of the inten-
sivists (Y.A., S.H. or R.G.). To minimize variability in data col-
lection, one physician (Y.A.) coordinated the overall process.
In addition, a written reference with the definitions used in
original articles was made. Patients aged 16 years or more
were eligible for the study with the exception of burn and
brain-dead patients. For patients admitted to the ICU more
than once in the same hospitalization, data from the first
admission were used. Approval from the hospital Ethics Com-
mittee was not required because the information had already
been collected for clinical reasons.
The following data were collected: demographics, APACHE II
and SAPS II scores, and MPM variables. MPM II0 data were
obtained on all admissions, whereas MPM II24, APACHE II
and SAPS II data were obtained on patients who stayed for
24 hours or more in ICU. APACHE II and SAPS II scores
were calculated in accordance with the original methodology,
using the worst physiologic values in the first ICU day [2,3].
The only exception was Glasgow Coma Score (GCS). Many
of these patients were under the influence of sedation and
the worst GCS would reflect the effect of sedation more than
the true underlying mental status. We therefore used the
worst GCS value for non-sedated patients and the pre-seda-
tion score for patients under sedation, as described previ-
ously [4,10–12]. The main reason for ICU admission, whether
the admission was after emergency surgery, and the pres-
ence of severe chronic illness were documented in accor-
dance with the original definitions [2]. Postoperative patients
with sepsis or cardiac arrest were included with non-opera-
tive patients with these conditions [2]. ICU and hospital
length of stay (LOS) and lead time (the interval from hospital
admission to ICU admission) were calculated. Vital status at
discharge from the ICU and from the hospital was registered.
Predicted hospital mortality was calculated with the logistic
regression formulas described originally [2–4]. Standardized
mortality ratio (SMR) was calculated by dividing observed
hospital mortality by the predicted hospital mortality. The
95% confidence intervals (CIs) for SMRs were calculated by
regarding the observed mortality as a Poisson variable, then
dividing its 95% CI by the predicted mortality [7].
Validation of the systems was tested by assessing calibration
and discrimination. Calibration (the ability to provide risk esti-
mate corresponding to the observed mortality) was assessed
by calibration curves and the Lemeshow–Hosmer goodness-
of-fit C-statistic [11]. Calibration curves were drawn by plot-
ting predicted against actual mortality for groups of the
patient population stratified by 10% increments of predicted
mortality. To calculate the C-statistic, the study population
was stratified into ten deciles with approximately equal
numbers of patients. The predicted and actual number of sur-
vivors and non-survivors were compared statistically with the
use of formal goodness-of-fit testing to determine whether or
not the discrepancy was statistically insignificant (P > 0.05).
Discrimination was tested by receiver operating characteristic
(ROC) curves and 2 × 2 classification matrices. ROC curves
were constructed as a measure of assessing discrimination
with 10% stepwise increments in predicted mortality [14,15].
The four curves were compared by computing the areas
under the curves. Classification matrices were performed at
decision criteria of 10%, 30% and 50%. Sensitivity, speci-
ficity, positive and negative predictive values and overall
correct classification rate were calculated.
Minitab for Windows (Release 12.1, Minitab Inc.) was used
to perform statistics. Continuous variables were expressed as
means ± SD and were compared by standard t-test. Categor-
ical values were expressed in absolute and relative frequen-
cies and were analyzed by χ2 test. Linear regression and
logistic regression analysis were used when appropriate.
P ≤ 0.05 was considered significant.
Results
During the study period there were 1084 admissions to the
ICU. Excluded patients were 94 re-admissions, 6 brain-dead
patients and 15 with incomplete data.
Patient population
The demographics of the 969 eligible patients are shown in
Table 1. It is noteworthy that 32% of all patients had one or
more severe chronic illnesses. Severe hepatic disease was
the leading chronic illness, followed by immunosuppression,
severe respiratory illness, renal illness and cardiovascular
illness. Some patients had more than one severe chronic
illness. In comparison with survivors, non-survivors wereCritical Care    April 2001 Vol 6 No 2 Arabi et al.
older, had a longer lead time and ICU LOS but shorter hospi-
tal LOS. They had higher APACHE II and SAPS II scores.
The type of admission was more likely to be medical or emer-
gency surgical in non-survivors, and to be elective surgical in
survivors. Severe chronic illness was more common in non-
survivors, especially liver disease.
Mortality predicted by the four systems
Table 2 shows the actual mortality and predicted mortality by
all four systems, and also SMRs and their 95% CIs. SMRs for
all system were not significantly different from 1, indicating
accurate overall mortality prediction.
Predicted mortality by subgroups
When subgrouped by categories of main reasons for ICU
admission (Table 3), SMRs by the four systems were not sig-
nificantly different from 1, with few exceptions. MPM II0 and
MPM II24 overestimated mortality for the category ‘non-opera-
tive trauma’ admissions, and SAPS II underestimated mortal-
ity for the category ‘other medical’. When subgrouped by the
Table 1
Patients’ demographics
Variable Total Survivors Non-survivors P value*
Total number 969 (100) 659 (100) 310 (100) –
Number of females 363 (37.46) 246 (37.33) 117 (37.74) NS
Age in years (mean ± SD) 49.09 ± 20.19 45.78 ± 20.09 56.15 ± 18.53 <0.001
Lead time in days (mean ± SD) 4.08 ± 8.93 3.66 ± 8.04  4.98 ± 10.53 0.05
ICU LOS in days (mean ± SD) 6.58 ± 9.76 5.99 ± 8.80  7.82 ± 11.44  0.01
Hospital LOS in days (Mean ± SD) 31.75 ± 43.80 35.17 ± 43.27  24.45 ± 44.14  <0.001
APACHE II score (mean ± SD) 18.85 ± 9.13 15.75 ± 7.46 25.63 ± 8.80 < 0.001
SAPS II score (mean ± SD) 38.02 ± 19.90 31.20 ± 15.63 52.98 ± 20.11 < 0.001
Type of admission
Medical 662 (68.32) 404 (61.31) 258 (83.23) <0.001
Elective surgical 173 (17.85) 155 (23.52) 18 (5.81) <0.001
Emergency surgical 134 (13.83) 100 (15.17) 34 (10.97) NS
Chronic illness:
Hepatic 121 (12.5) 32 (4.86) 89 (28.71) <0.001
Cardiovascular 35 (3.62) 24 (3.64) 11 (3.55) NS
Renal 54(5.58) 32(4.86) 22 (7.10) NS
Respiratory 68 (7.02) 55 (8.35) 13 (4.19) 0.02
Immunosuppression 85 (8.78) 39 (5.92) 46 (14.84) <0.001
Any of the above 310 (32.02) 166 (25.19) 144 (46.45) <0.001
ICU mortality 204 (21.05) 0 204 (65.81)
Figures in parentheses are percentages. *Survivors versus non-survivors. LOS, length of stay; NS, not significant.
Table 2
Mortalities predicted by the four systems
System N Actual mortality Predicted mortality SMR 95% CI Survivors Non-survivors
MPM II0 969 0.320 0.319 1.00 0.91–1.10 0.190 ± 0.205 0.592 ± 0.307*
MPM II24 681 0.316 0.341 0.92 0.82–1.03 0.221 ± 0.220 0.602 ± 0.290*
APACHE II 681 0.316 0.315 1.00 0.89–1.11 0.213 ± 0.211 0.536 ± 0.279*
SAPS II 681 0.316 0.290 1.09 0.97–1.21 0.189 ± 0.215 0.507 ± 0.311*
*P < 0.001 for survivors versus non-survivors. CI, confidence interval.source of admission, all SMRs were not significantly different
from 1 with the exception of the underestimation of mortality
of SAPS II for patients admitted from the floor.
Calibration
Calibration curves are shown in Figure 1. Of the four systems,
SAPS II stands out as deviating from the identity line in most
of the strata, including those with large numbers of patients.
The SAPS II curve shows an underestimation of mortality in
low-risk patients and an overestimation of mortality in high-
risk patients, leading to the skewed appearance of its calibra-
tion curve. The curves of the other three systems fell on the
identity line in the strata with large number of patients and
deviated in some other strata.
The results of Lemeshow–Hosmer goodness-of-fit tests are
shown in Table 4. The C-statistic was best for MPM II24
(14.71), with P = 0.06. For the other three systems, calibra-
tion tested by the C-statistic was poor. These results indicate
that, of the four systems, MPM II24 had the least statistically
significant discrepancy between predicted and observed
mortality across the strata of increasing predicted mortality.
Discrimination
Figure 2 shows the receiver operating characteristic (ROC)
curves for the four systems. The corresponding areas under the
curves were as follows: MPM II0, 0.85; MPM II24, 0.84;
APACHE II, 0.83; SAPS II, 0.79. These reflect the better dis-
criminative power of the first three systems than that of SAPS II.
The results of the 2 × 2 classification matrix are shown in
Table 5. The overall correct classification rate was highest for
MPM II0 and lowest for SAPS II at the different cutoff points;
MPM II24 and APACHE II had intermediate rates. This was
consistent with the results of ROC curve testing.
Correlation of predicted mortalities by the four systems
On the basis of linear regression analysis, mortalities pre-
dicted by all four systems correlated with each other
(P < 0.001 for all combinations). The closest correlation was
between MPM II0 and MPM II24 (r2 = 0.67) followed by
APACHE II and SAPS II24 (r2 = 0.66), MPM II24 and SAPS II
(r2 = 0.62), MPM II24 and APACHE II (r2 = 0.56), MPM II0 and
SAPS II (r2 = 0.52) and MPM II0 and APACHE II (r2 = 0.48).
Figure 3 shows plots for the highest and lowest correlations.
The effect of lead time and ICU LOS on hospital mortality
By univariate analysis, lead time was a significant predictor of
hospital outcome (odds ratio 1.02, 95% CI 1.00–1.03 per
day,  P = 0.04). However, when adjusted to the severity of
illness estimated from the mortality predicted by any of the
four systems, lead time was not an independent predictor of
hospital outcome. Similarly, ICU LOS was a significant pre-
dictor of hospital outcome by univariate analysis (odds ratio
1.02, 95% CI 1.00–1.03 per day, P = 0.01) but not when
adjusted to severity of illness by multivariate analysis.
Discussion
The main findings of this validation study on a Saudi Arabian
ICU population can be summarized as follows: (1) overall
mortality prediction, estimated by SMR, was reasonably accu-
rate, especially for MPM II0 and APACHE II; (2) MPM II24 had
the best calibration by C-statistic; (3) SAPS II had the lowest
calibration and discrimination.
Available online http://ccforum.com/content/6/2/166
Table 3
Standardized mortality ratios for the four systems by reason of admission and source of admission
Patients with 
All patients LOS ≥24 h Standardized mortality ratio (95% confidence interval)
Subcategory N Died N Died MPM II0 MPM II24 APACHE II SAPS II
Reason for admission
Respiratory 156 46 132 39 1.21 (0.92–1.50) 1.07 (0.79–1.35) 0.93 (0.69–1.18) 1.29 (0.95–1.63)
Cardiovascular 222 132 152 82 1.07 (0.96–1.19) 0.98 (0.84–1.12) 0.99 (0.84–1.13) 1.05 (0.90–1.21)
Neurological 58 20 43 16 0.91 (0.59–1.23) 0.96 (0.59–1.33) 1.17 (0.72–1.62) 1.39 (0.85–1.93)
Other medical 87 41 63 32 1.02 (0.79–1.25) 1.05 (0.80–1.31) 1.05 (0.79–1.31) 1.32(1.00–1.63)
Non-op. trauma 146 24 126 18 0.73 (0.46–0.99) 0.60 (0.34–0.85) 1.09 (0.62–1.56) 0.73 (0.42–1.04)
Op. trauma 52 11 37 6 0.83 (0.40–1.27) 0.75 (0.20–1.30) 1.21 (0.32–2.10) 0.75 (0.20–1.31)
Post-op. 241 30 127 21 0.79 (0.53–1.05) 0.79 (0.48–1.10) 0.89 (0.54–1.24) 1.04 (0.64–1.45)
Source of admission
Emergency room 312 87 224 53 0.89 (0.73–1.05) 0.77 (0.59–0.95) 0.94 (0.72–1.16) 0.93 (0.71–1.14)
Floor 292 149 228 107 1.11 (0.99–1.24) 1.02 (0.88–1.16) 1.02 (0.88–1.16) 1.18 (1.01–1.34)
Operating room 307 52 179 38 0.89 (0.67–1.11) 0.85 (0.61–1.08) 1.01 (0.72–1.29) 1.06 (0.76–1.36)
Other hospital 58 22 50 17 1.21 (0.81–1.61) 1.21 (0.75–1.68) 1.09 (0.67–1.51) 1.29 (0.79–1.79)
LOS, length of stay.There is great international variability in patient mix and sever-
ity of illness [7–9,16–18]. Some of the differences are inher-
ent in the patient population. For example, patients with
cirrhosis have a high severity of illness and poor prognosis
when admitted to the ICU [19–21]. Case mix is also affected
by the type of hospital, for example whether it is primary or
tertiary, or a transplant or trauma center. Patients referred
from other hospitals have a higher severity of illness and mor-
tality compared with direct admissions [22]. Other factors are
practice-related. An important example is the ‘do not-resusci-
tate’ (DNR) practice [23,24]. Early (pre-ICU) determination of
DNR status reduces the number of futile admissions to the
ICU leading to a probable reduction in overall severity of
illness. Another example is related to ICU bed availability. It
has been documented that physicians tend to be more selec-
tive in their ICU admissions at times of bed shortages, with
patients with higher severity of illness being admitted [25]. In
our study, the relatively high level of severity of illness was
probably related to a combination of all these factors. Being a
tertiary care center, our hospital receives referrals from other
hospitals, some of them directly to ICU (Table 2). Being a
transplant center, we have a large population of end-stage
liver disease. The concept of DNR is evolving in Saudi Arabia.
Our hospital has been leading in the country in this field by
establishing a written policy for DNR orders and raising the
awareness among physicians about this issue. Nevertheless,
there is room for improvement. Frequently the DNR status is
discussed at a very late stage or is not discussed at all before
Critical Care    April 2001 Vol 6 No 2 Arabi et al.
Figure 1
Calibration curves for the four mortality prediction systems.admission to the ICU. Consequently, many desperately ill
patients are admitted to the ICU with very high severity of
illness and no meaningful chance of survival. The nursing
shortage in our ICU led to selecting the sicker admissions
and decreasing the number of elective admissions.
In this study we showed that the overall mortality prediction
was accurate but calibration was inadequate. Potential
reasons for insufficient calibration might include the following:
(1) factors related to the calibration methodology itself; (2)
reasons related to data collection, namely intra-observer and
interobserver variability; (3) variability in GCS; (4) differences
in case mix; (5) differences in DNR policies; and (6) differ-
ences in medical care.
The results of Lemeshow–Hosmer statistics are dependent not
only on the calibration of the model but also on patient numbers
and the distribution of the estimates [26]. The results of the cali-
bration tests in our study might seem inconsistent with the
overall estimate of mortality of the whole population and with the
mortality estimates of the subgroups (Table 2). This apparent
inconsistency is probably related to the distribution of estimates.
The overestimation of mortality in certain strata of severity of
illness is ‘counterbalanced’ by underestimation in other strata
(Table 4), leading to ‘perfect’ estimation when the whole popula-
tion or a specific subgroup is considered.
Interobserver variability in data collection has been docu-
mented in several studies [27–29]. This is potentially relevant
Available online http://ccforum.com/content/6/2/166
Table 4
Hosmer–Lemeshow goodness-of-fit tests
MPM II0 MPM II24
Decile N PD AD PS AS Decile N PD AD PS AS
1 96 1.46 5 94.54 91 1 68 1.32 1 66.68 67
2 97 3.43 6 93.57 91 2 68 3.04 7 64.96 61
3 97 6.38 10 90.62 87 3 68 5.23 6 62.77 62
4 97 9.48 4 87.52 93 4 69 8.72 7 60.28 62
5 97 15.85 22 81.15 75 5 68 12.60 14 55.40 54
6 97 23.05 26 73.95 71 6 68 19.88 17 48.12 51
7 97 35.47 27 61.53 70 7 68 29.04 21 38.96 47
8 97 50.99 55 46.01 42 8 68 38.89 36 29.11 32
9 97 71.98 68 25.02 29 9 68 50.88 46 17.12 22
10 96 90.39 87 5.61 9 10 68 62.86 60 5.14 8
C-statistic: 26.61 P value: <0.001 C-statistic: 14.71 P value: 0.06
APACHE II SAPS II
Decile N PD AD PS AS Decile N PD AD PS AS
1 70 1.53 2 68.47 68 1 71 0.74 3 70.26 68
2 68 3.57 2 64.43 66 2 72 2.16 8 69.84 64
3 69 5.82 7 63.18 62 3 65 3.76 8 61.24 57
4 68 9.15 11 58.85 57 4 74 7.13 11 66.87 63
5 66 12.37 18 53.63 48 5 72 10.79 15 61.21 57
6 68 17.28 13 50.72 55 6 63 13.98 21 49.02 42
7 69 24.68 35 44.32 34 7 68 22.09 24 45.91 44
8 66 32.39 25 33.61 41 8 68 33.70 31 34.30 37
9 70 48.57 49 21.43 21 9 64 45.54 42 18.46 22
10 67 59.24 53 7.76 14 10 64 57.24 52 6.76 12
C-statistic: 21.87 P value: 0.005 C-statistic: 43.36 P value: <0.001
Degrees of freedom = 8. PD, predicted to die; PS, predicted to survive; AD, actually died; AS, actually survived.to our study because data collection was performed by
several physicians and over a relatively long period
(22 months). We tried to minimize variability by having a
written reference of definitions based on the original articles of
the various scoring systems and having one person coordinate
the process of data collection. Similar approaches have been
shown to minimize variability [30,31]. MPM II systems have
been documented to have high reproducibility, which might
explain the better calibration of MPM II24 in our study [32].
The variability of GCS determination in sedated patients
accounts for much of the variability in scoring APACHE II.
Several approaches in determining GCS have been used
previously. For non-sedated patients we used the worst value
in the first 24 hours; for sedated patients we used the pre-
sedation GCS. This approach has been shown to be associ-
ated with better performance of APACHE II than the
approach that assumes normal GCS for sedated patients
[10]. This approach also follows the original MPM II article
definitions [4] and is consistent with the approach described
by Knaus and others [11,12].
Another potential reason for the inadequate calibration is the
differences in case mix between our database and the devel-
opment databases of the mortality prediction systems.
Medical patients constitute a larger proportion in our data-
base (68%) than in the development databases (MPM II0,
45%; MPM II24, 48%; SAPS II, 49%; APACHE II, 58%)
[2–4]. When the main diagnostic categories in our database
are compared with those in the development database of
APACHE II, some interesting differences appear. The post
cardiac arrest category, which is associated with a high mor-
tality risk (APACHE II diagnostic category weight is 0.393)
accounts for 7% of our admissions, compared with 3% in the
developmental database of APACHE II. The postoperative
category ‘peripheral vascular surgery’, which is associated
with a low mortality risk (APACHE II diagnostic weight is
Critical Care    April 2001 Vol 6 No 2 Arabi et al.
Figure 2
Receiver operating characteristic (ROC) curves for the four systems.
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Figure 3
Plots of predicted mortality of the systems with the highest intersystem correlation (MPM II0 versus MPM II24, left) and the lowest intersystem
correlation (MPM II0 versus APACHE II, right).–1.315) accounts for 1.5% of our admissions, compared with
9.82% of the development database. Our database also has
more severe chronic illnesses (32%) compared with 5–29%
in different participating ICUs in the APACHE II development
database. This is partly related to the high percentage of
patients with end-stage liver disease admitted to our ICU
(12.5% of all patients).
Differences in admission practises to the ICUs might also
have an impact on ICU outcome. The delay in DNR orders is
mentioned earlier. This factor probably contributes to our high
severity of illness and could have affected system calibration.
Finally, one must examine whether the inadequate calibration
is related to differences in medical care. However, in our
study, overall actual mortality was not different from predicted
mortality, as is evident in the SMRs (Table 2). Furthermore,
when the calibration curves are examined there is no consis-
tent pattern of overestimation or underestimation of mortality
among the four systems in the different strata of severity of
illness. This suggests that the inadequate calibration is inher-
ent in these systems when applied to this population and less
likely to be related to gross variation in medical care.
Our study has some limitations. First, it is a single-center
study, which makes it biased towards a certain case mix.
Second, as discussed above, collecting the data over a rela-
tively long period by different physicians has implications for
consistency of data collection. The use of a written reference
of definitions and assigning a coordinator to oversee the
whole process probably decreased variability, as has been
shown previously [28,29]. In addition, variability has been
found to be random and of little impact on the overall esti-
mates [29]. A multicenter study would have addressed some
of these concerns.
In conclusion, the four mortality prediction systems gave accu-
rate overall estimates of mortality, especially MPM II0 and
APACHE II. Calibration was modest for MPM II24 and inade-
quate for the others. SAPS II had the lowest calibration and
discrimination. The local performance of MPM II systems (par-
ticularly MPM II24), in addition to their ease of use, makes them
attractive models for use in Saudi Arabia. However, a multi-
center national study is needed to confirm these findings.
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